Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 28Breast Neoplasms 12Prostatic Neoplasms 9Rectal Neoplasms 5Pancreatic Neoplasms 5Lung Neoplasms 4Gastrointestinal Neoplasms 4Colonic Neoplasms 4Stomach Neoplasms 3Neoplasms 3Endometrial Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Uterine Cervical Neoplasms 2Pain 2Neoplasms, Plasma Cell 2Low Anterior Resection Syndrome 2Disease 2Vulvar Neoplasms 1Vomiting 1Total Exenteration 1Thyroid Neoplasms 1Thyroid Diseases 1Prediabetic State 1Obesity, Morbid 1Non-resectable Metastatic Cancer of the Lung 1Neoplastic Syndromes, Hereditary 1Nausea 1Multiple Myeloma 1Motor Activity 1Lymphoma 1

Interventions

Ursodeoxycholic Acid 1Surveys and Questionnaires 1Standard of Care 1Interviews as Topic 1High-Throughput Nucleotide Sequencing 1Genetic Testing 1Genetic Counseling 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Syndromes, Hereditary × Interviews as Topic × Gastrointestinal × Clear all
NCT04763915 2025-09-19

IMPACT

Vanderbilt-Ingram Cancer Center

Phase NA Active not recruiting
720 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡